Margette Dialysis is a medicare approved dialysis facility center in Baytown, Texas and it has 12 dialysis stations. It is located in Chambers county at 10424 Interstate 10 East, Baytown, TX, 77523.
You can reach out to the office of Margette Dialysis at (281) 573-3234. This dialysis clinic is managed and/or owned by Davita. Margette Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 2017. The medicare id for this facility is 672826 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | Margette Dialysis |
|---|
| Location | 10424 Interstate 10 East, Baytown, Texas |
|---|
| No. of Dialysis Stations | 12 |
|---|
| Medicare ID | 672826 |
|---|
| Managed By | Davita |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | Yes |
|---|
NPI Associated with this Dialysis Facility:
Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Margette Dialysis
from NPPES records by matching pattern on the basis of name, address, phone number etc.
Please use this information accordingly.
Patient Distribution
Dialysis Adequacy
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
- Hemodialysis
| Adult patients getting regular hemodialysis at the center | 4 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 34 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center | |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at Margette Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 5 |
| Hypercalcemia patient months | 38 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 2 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL | |